If you liked this article you might like

Biotech Movers: Ultragenyx Jumps on Phase Three Burosumab Data
Biotech Premarket Movers: Insys, Ultragenyx, Alexion
Battered Pharma Stocks Bounce Back, Could Boost Retirement Portfolios
These 5 Stocks Are Breaking Out This Summer